Patent details
EP2183270 Title: USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7
Basic Information
- Publication number:
- EP2183270
- PCT Application Number:
- PCT/EP/2008/060693
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088030374
- PCT Publication Number:
- WO/2009/024528
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7
- French Title of Invention:
- UTILISATION DE DÉPSIPEPTIDES CYCLIQUES POUR INHIBER LA KALLIKRÉINE 7
- German Title of Invention:
- VERWENDUNG CYCLISCHER DEPSIPEPTIDE ZUR KALLIKREIN 7-HEMMUNG
- SPC Number:
Dates
- Filing date:
- 14/08/2008
- Grant date:
- 17/12/2014
- EP Publication Date:
- 17/12/2014
- PCT Publication Date:
- 26/02/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/05/2010
- EP B1 Publication Date:
- 17/12/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/08/2015
- Expiration date:
- 14/08/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/08/2008
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- KRASTEL Philipp
- Address:
- Germany (DE)
2
- Name:
- LIECHTY Brigitta-Maria
- Address:
- Switzerland (CH)
3
- Name:
- SCHMITT Esther
- Address:
- Germany (DE)
4
- Name:
- SCHREINER Erwin Paul
- Address:
- Austria (AT)
Priority
- Priority Number:
- 07114505
- Priority Date:
- 17/08/2007
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- C07K 7/56;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|